Science doesn't believe in MAGIC

Following a final report from a prominent South Korean university, __Science__ formally retracted a paper today (Apr. 23) from Korean researcher Kim Tae-kook purportedly reporting a new technology to identify drug targets called magnetism-based interaction capture (MAGIC). Kim Tae-kookImage: AFP/KAISTIn linkurl:February 2008,;http://www.the-scientist.com/blog/display/54398/ Kim was suspended from the Korea Advanced Institute of Science and Technology (KAIST), where he was a faculty member, afte

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Following a final report from a prominent South Korean university, __Science__ formally retracted a paper today (Apr. 23) from Korean researcher Kim Tae-kook purportedly reporting a new technology to identify drug targets called magnetism-based interaction capture (MAGIC).
Kim Tae-kook
Image: AFP/KAIST
In linkurl:February 2008,;http://www.the-scientist.com/blog/display/54398/ Kim was suspended from the Korea Advanced Institute of Science and Technology (KAIST), where he was a faculty member, after a preliminary report from the university investigating two of his studies concluded that "the two papers do not contain any scientific truth." The studies -- the now-retracted Science paper, published in 2005, and a 2006 paper in__ linkurl:Nature Chemical Biology;http://www.nature.com/nchembio/journal/v2/n7/abs/nchembio800.html __(NCB) -- characterized MAGIC, a way to use magnetized nanoparticles to track protein movements in order to find new molecular drug targets. The __NCB__ paper was retracted last July, before the KAIST committee had wrapped up its internal investigation. All nine of the study's authors signed the linkurl:retraction letter,;http://www.nature.com/nchembio/journal/v4/n7/full/nchembio0708-431.html including Kim, although Kim maintained in an editor's note that the scientific irregularities were confined to only one figure in the paper. __Science__ published an "editorial expression of concern" in March 2008 and started discussing the text of a retraction with Kim in May 2008, but "had concerns with some of [Kim's] proposed language," linkurl:Natasha Pinol,;http://www.aaas.org/news/media_contacts/ a __Science__ spokesperson, told __The Scientist__ in an email. The journal then waited for KAIST's final ruling, which it received and had translated into English last month, before deciding conclusively that many of the results in the 2005 study had been fabricated. Original notebooks and data from both studies have gone missing, according to both the __Science__ and __NCB__ retractions, and so cannot be used to substantiate the findings of the papers. "Since almost a year elapsed between the interim findings and release of the final report to us, we decided that we were not willing to enter into negotiations regarding the wording of the retraction," said Pinol. "Dr. Kim did offer to sign the retraction with some modifications but we did not accept his offer." Instead, the journal opted for an "editorial retraction" authored by editor-in-chief linkurl:Bruce Alberts.;http://www.sciencemag.org/help/about/management.dtl#section_bruce-alberts-editor-in-chief
**__Related stories:__***linkurl:Korean researcher fired for fraud;http://www.the-scientist.com/blog/display/54398/
[3rd March 2008]*Authors retract Science paper
[26th July 2007]*linkurl:All Hwang human cloning work fraudulent;http://www.the-scientist.com/news/display/22933/
[10th January 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies